NAMDC: Exploring the Clinical Utility of Growth Differentiation Factor 15 as a Biomarker for Primary Mitochondrial Disorders

Jan 29, 2025 · 2m 45s
NAMDC: Exploring the Clinical Utility of Growth Differentiation Factor 15 as a Biomarker for Primary Mitochondrial Disorders
Description

New research from the North American Mitochondrial Disease Consortium (NAMDC). This summary is based on a paper published in the Journal of Inherited Metabolic Disease on November 24, 2024, titled...

show more
New research from the North American Mitochondrial Disease Consortium (NAMDC). This summary is based on a paper published in the Journal of Inherited Metabolic Disease on November 24, 2024, titled "The clinical utility in hospital-wide use of growth differentiation factor 15 as a biomarker for mitochondrial DNA-related disorders." 

Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/jimd.12821

Learn more about NAMDC: https://namdc.rarediseasesnetwork.org
show less
Information
Author RDCRN
Organization RDCRN
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search